Advertisement
Screener

CLARUS THERAPEUTICS HOLDINGS, INC. Quick Ratio

CLARUS THERAPEUTICS HOLDINGS, INC. Quick Ratio

  • Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2022-06-30..

Quick ratio

Overview →

Financial period ending 2022-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Quick ratio · latest quarter(m)Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2022-06-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash, securities and trade receivables(m)Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current
Current obligations61.81M USDLiabilities, Current
Cash and equivalents19.17M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables8.71M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory · excluded from quick assets16.80M USDInventory, Net

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCash, securities and trade receivables (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory · excluded from quick assets (USD)Quick ratio
2022-06-30(m)$61.81M$19.17M(m)$8.71M$16.80M(m)
2022-03-31(m)$65.95M$9.14M(m)$8.01M$14.93M(m)
2021-12-31(m)$66.06M$26.41M(m)$6.34M$14.21M(m)
2021-09-30(m)$64.38M$21.95M(m)$6.93M$12.48M(m)
2021-06-30(m)$1.34M$224.53K(m)(m)(m)(m)
2021-03-31(m)$696.03K$408.19K(m)(m)(m)(m)
2020-12-31(m)$59.81M$7.23M(m)$4.40M$5.86M(m)
2020-09-30(m)(m)$13.15M(m)(m)(m)(m)
2019-12-31(m)(m)$1.66M(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.